VALMET OYJ/ FI4000074984 /
30/05/2024 8:11:26 | Diferencia -0.820 | Volumen | Bid17:36:14 | Ask17:36:14 | Capitalización de mecado | Dividendo A. | P/E Ratio |
---|---|---|---|---|---|---|---|
24.310EUR | -3.26% | 0 Volumen de negocios: 0.000 |
-Volumen de oferta: - | -Tamaño/ Volumen/ Formato de Ask: - | 4.5 mil millonesEUR | 5.53% | 12.59 |
GlobeNewswire
7:05
Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD
GlobeNewswire
7:05
Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD
GlobeNewswire
7:00
Update on FDA Priority Review of Dupixent® (dupilumab) for the Treatment of COPD Patients with Type ...
GlobeNewswire
7:00
Press Release: Update on FDA priority review of Dupixent for the treatment of COPD patients with typ...
GlobeNewswire
7:00
Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024
GlobeNewswire
6:08
Sen. John Cornyn delivers remarks at Driscoll Children's Hospital Rio Grande Valley
GlobeNewswire
5:00
Flash News: OKX to List Ultiverse's Token on its Spot Market, Expanding Trading Options
GlobeNewswire
4:38
Avaada Energy Secures 1050 MWp Solar Project in NTPC Auction; Crosses over 15 GWp Portfolio in India
GlobeNewswire
3:41
United States Government to Reinstate Section 301 Import Tariffs on Artificial Graphite from China
GlobeNewswire
3:16
Lowey Dannenberg, P.C. is Investigating Akero Therapeutics, Inc. (“Akero”) (NASDAQ: AKRO) for Potent...
GlobeNewswire
3:00
ENPHASE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Agai...
GlobeNewswire
3:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Spr...
GlobeNewswire
3:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Int...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página